Business / Finance

RSS

Epion Health closes $4.5M Series A financing round with Deerfield Management

Epion Health announced the closing of a $4.5M Series A financing round with Deerfield Management Company, a New York City based investment firm.

18 Jul 2014

Sound Physicians acquires certain assets of Inpatient Specialists

Sound Physicians, a leading hospitalist organization, focused on driving improvements in the quality, satisfaction and financial performance of inpatient healthcare delivery, announced an acquisition of certain assets of Inpatient Specialists.

18 Jul 2014

Virobay announces closing of expanded Series B second tranche financing

Virobay, Inc., a clinical stage pharmaceutical company with a platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune disease and fibrosis, today announced the closing of an expanded Series B second tranche financing of $8.0 million.

16 Jul 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%.

15 Jul 2014

Pfizer to in-license Absorption Systems' BCRP-MDCK cells

Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).

15 Jul 2014

CVS Caremark enters into definitive agreement to acquire Navarro Discount Pharmacy

CVS Caremark today announced that it has entered into a definitive agreement to acquire the assets of Miami-based Navarro Discount Pharmacy, the largest Hispanic-owned drugstore chain in the U.S. The transaction includes Navarro's 33 retail drugstore locations and Navarro Health Services, a specialty pharmacy serving patients with complex or chronic diseases.

14 Jul 2014

Arrowroot Capital makes $4 million investment in MedNet Solutions

MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Arrowroot Capital, a growth equity firm focused on software-as-a-service (SaaS) and Internet-based businesses, has made a $4 million investment in MedNet Solutions.

14 Jul 2014

Mylan enters into definitive agreement to acquire Abbott's branded generics pharmaceuticals business

Mylan Inc. today announced that it has entered into a definitive agreement with Abbott whereby Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business ("the Assets") in an all-stock transaction.

14 Jul 2014

Abattis Bioceuticals qualified to trade on OTCQX

OTC Markets Group Inc., operator of Open, Transparent and Connected financial marketplaces, today announced that Abattis Bioceuticals Corp., a specialty biotechnology company, has qualified to trade on OTCQX®, the best marketplace.

11 Jul 2014

Kainos Capital announces acquisition of Unilever's Slim-Fast brand

Kainos Capital, a firm specializing in acquiring and managing food and consumer brands, today announced that it has acquired the Slim-Fast brand from Unilever. Unilever will retain a minority stake in the business. Terms of the transaction were not disclosed.

11 Jul 2014

Baxter International acquires drug candidate developed to treat sickle cell disease

A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.

11 Jul 2014

Aviv acquires two ALFs and one post-acute and long-term care SNF for $82 million

Aviv REIT, Inc. announced today it has acquired two assisted living facilities ("ALFs") and one post-acute and long-term care skilled nursing facility ("SNF") for $82.0 million (the "Acquisition"), and two parcels of land and the entitlements for the construction of two new ALFs and a 50 unit addition to one of the existing ALFs for $12.2 million (the "New Construction Projects"), all of which are located in Massachusetts, for a total of $94.2 million.

11 Jul 2014

Mercy Memorial Hospital System signs LOI to join Promedica

Mercy Memorial Hospital System signed a letter of intent to join ProMedica, a not-for-profit, multi-hospital system based in Toledo, Ohio.

9 Jul 2014

Battelle acquires nearly 11% of AMIC's outstanding Common Stock

Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC's outstanding Common Stock.

7 Jul 2014

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.

7 Jul 2014

BBSRC announce launch of Crossing Biological Membranes’ network

The BBSRC, with support from EPSRC, have committed £18M to fund 13 unique collaborative Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB).

4 Jul 2014

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.

4 Jul 2014

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

2 Jul 2014

Eurofins Genomics, AmpTec sign co-marketing agreement for IVT-RNAs

Eurofins Genomics, international market leader in genomic services, and AmpTec, internationally recognized provider of RNA technology products, have agreed on non-exclusively co-marketing AmpTec's IVT-RNAs globally.

2 Jul 2014

Business / Finance

Epion Health closes $4.5M Series A financing round with Deerfield Management

Sound Physicians acquires certain assets of Inpatient Specialists

Virobay announces closing of expanded Series B second tranche financing

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Pfizer to in-license Absorption Systems' BCRP-MDCK cells

CVS Caremark enters into definitive agreement to acquire Navarro Discount Pharmacy

Arrowroot Capital makes $4 million investment in MedNet Solutions

Mylan enters into definitive agreement to acquire Abbott's branded generics pharmaceuticals business

Abattis Bioceuticals qualified to trade on OTCQX

Kainos Capital announces acquisition of Unilever's Slim-Fast brand

Baxter International acquires drug candidate developed to treat sickle cell disease

Aviv acquires two ALFs and one post-acute and long-term care SNF for $82 million

Mercy Memorial Hospital System signs LOI to join Promedica

Battelle acquires nearly 11% of AMIC's outstanding Common Stock

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

BBSRC announce launch of Crossing Biological Membranes’ network

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Eurofins Genomics, AmpTec sign co-marketing agreement for IVT-RNAs

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

Latest News